Neurogene (NGNE) Accumulated Depreciation & Amortization (2018 - 2025)

Historic Accumulated Depreciation & Amortization for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to $800000.0.

  • Neurogene's Accumulated Depreciation & Amortization changed 0.0% to $800000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $800000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.2 million for FY2024, which is 303.03% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Accumulated Depreciation & Amortization is $800000.0, which was down 0.0% from $800000.0 recorded in Q2 2025.
  • Neurogene's Accumulated Depreciation & Amortization's 5-year high stood at $3.3 million during Q4 2023, with a 5-year trough of $749000.0 in Q1 2025.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $800000.0 (2023), whereas its average is $1.2 million.
  • As far as peak fluctuations go, Neurogene's Accumulated Depreciation & Amortization increased by 24.63% in 2024, and later tumbled by 798.53% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Accumulated Depreciation & Amortization stood at $3.3 million in 2023, then dropped by 3.03% to $3.2 million in 2024, then crashed by 75.0% to $800000.0 in 2025.
  • Its Accumulated Depreciation & Amortization stands at $800000.0 for Q3 2025, versus $800000.0 for Q2 2025 and $749000.0 for Q1 2025.